This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Charlotte, NC-based Albemarle Corporation is a premier specialty chemicals company with leading positions in attractive end markets globally. It is a leading producer of highly-engineered specialty chemicals geared to meet customer requirements across a bevy of end markets including petroleum refining, consumer electronics, energy storage, construction and automotive.
Newmont (NEM) to Post Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Newmon''s (NEM) results in the third quarter are likely to reflect the weakness in gold prices.
Methanex (MEOH) to Post Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Methanex's (MEOH) third-quarter performance is likely to reflect healthy methanol demand and improvement in pricing.
Can Linde (LIN) Keep the Earnings Surprise Streak Alive in Q3?
by Zacks Equity Research
Higher industrial gas sales are likely to have aided Linde???s (LIN) Q3 earnings.
U.S. Steel (X) to Post Q3 Earnings: What's in the Cards?
by Zacks Equity Research
U.S. Steel's (X) Q3 results are likely to have benefited from strong demand across end markets and higher domestic steel prices.
HUN vs. ALB: Which Stock Is the Better Value Option?
by Zacks Equity Research
HUN vs. ALB: Which Stock Is the Better Value Option?
Sherwin-Williams (SHW) to Post Q3 Earnings: What's in Store?
by Zacks Equity Research
Sherwin-Williams' (SHW) third-quarter performance is likely to reflect strong demand and cost-control initiatives.
4 Chemical Stocks Set to Pull Off a Beat This Earnings Season
by Anindya Barman
Strong end-market demand and benefits of self-help actions are likely to reflect on the Q3 performance of Westlake (WLK), Tronox (TROX) and Chemours (CC) and Albemarle (ALB).
Olin (OLN) to Report Q3 Earnings: What's in the Offing?
by Zacks Equity Research
Olin's (OLN) Q3 performance is likely to have benefited from productivity actions and strong performance in the Winchester business.
Celanese (CE) to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
Celanese's (CE) Q3 performance is likely to have benefited from productivity actions, investments in high-return organic projects and strategic acquisitions.
PPG Industries (PPG) to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
PPG Industries' (PPG) performance is likely to have benefited from strong demand as well as cost-cutting and restructuring actions in Q3.
Can Albemarle (ALB) Keep the Earnings Surprise Streak Alive?
by Zacks Equity Research
Albemarle (ALB) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
UNVR vs. ALB: Which Stock Is the Better Value Option?
by Zacks Equity Research
UNVR vs. ALB: Which Stock Is the Better Value Option?
Albemarle (ALB) Inks Deal to Acquire Guangxi Tianyuan for $200M
by Zacks Equity Research
Albemarle's (ALB) acquisition of Tianyuan is a part of its strategy to pursue profitable growth, which is in line with customer demand.
4 Diversified Chemical Stocks to Watch Out for Amid Industry Woes
by Anindya Barman
Raw material cost pressure and demand worries due to chip shortage and the spread of the Delta variant pose as headwinds for the Zacks Chemicals Diversified industry. DOW, OLN, CC and AVNT are poised to survive the industry challenges.
Why Is Albemarle (ALB) Up 11.6% Since Last Earnings Report?
by Zacks Equity Research
Albemarle (ALB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
DOW vs. ALB: Which Stock Is the Better Value Option?
by Zacks Equity Research
DOW vs. ALB: Which Stock Is the Better Value Option?
Albemarle (ALB) Earnings Surpass Estimates in Q2, Sales Lag
by Zacks Equity Research
Albemarle (ALB) benefits from higher sales from its Lithium and Bromine business segments in the second quarter.
Albemarle (ALB) Q2 Earnings Top Estimates
by Zacks Equity Research
Albemarle (ALB) delivered earnings and revenue surprises of 7.23% and -1.68%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Albemarle (ALB) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Albemarle (ALB) is likely to have benefited from higher volumes and prices in its lithium business in the second quarter.
Strength Seen in Albemarle (ALB): Can Its 4.3% Jump Turn into More Strength?
by Zacks Equity Research
Albemarle (ALB) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Earnings Preview: Albemarle (ALB) Q2 Earnings Expected to Decline
by Zacks Equity Research
Albemarle (ALB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
DOW vs. ALB: Which Stock Is the Better Value Option?
by Zacks Equity Research
DOW vs. ALB: Which Stock Is the Better Value Option?
Albemarle's (ALB) Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Albemarle Corporation (ALB).
Albemarle (ALB) Moves 6.8% Higher: Will This Strength Last?
by Zacks Equity Research
Albemarle (ALB) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Albemarle (ALB) Opens Battery Materials Innovation Center
by Zacks Equity Research
Albemarle's (ALB) BMIC is projected to be fully operational this month and will support its lithium hydroxide, lithium carbonate and advanced energy storage materials growth platforms.